{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T01:42:45Z","timestamp":1771378965942,"version":"3.50.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974103, 82000747"],"award-info":[{"award-number":["81974103, 82000747"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Abnormal iron metabolism is related to the risk of diabetes, but the underlying mechanism of this association remains uncertain. This study was conducted to evaluate the contributions of systemic iron status to \u03b2-cell function and insulin sensitivity of patients with newly diagnosed T2DM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 162 patients with newly diagnosed T2DM and 162 healthy controls were enrolled in the study. Basic characteristics, biochemical indicators, and iron metabolism biomarkers, including serum iron (SI), ferritin (SF), transferrin (Trf), and transferrin saturation (TS), were collected. All patients underwent a 75\u00a0g oral glucose tolerance test. A series of parameters for assessing \u03b2-cell function and insulin sensitivity were calculated. The multivariate stepwise linear regression model was used to investigate the contributions of iron metabolism to \u03b2-cell function and insulin sensitivity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with healthy controls, patients with newly diagnosed T2DM had significantly higher levels of SF. Among the diabetic patients, the SI and TS levels were higher, and the percentage of Trf levels below normal values was lower in men than in women. In all diabetic patients, SF was the independent risk factor associated with impaired \u03b2-cell function. Further stratification analysis showed that Trf was an independent protective factor for \u03b2-cell function in male patients, while SF was an independent risk factor for impaired \u03b2-cell function in female patients. However, systemic iron status did not affect insulin sensitivity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Elevated SF levels and decreased Trf levels had a profound effect on impaired \u03b2-cell function in Chinese patients with newly diagnosed T2DM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1143919","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:03:47Z","timestamp":1680519827000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Association between systemic iron status and \u03b2-cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes"],"prefix":"10.3389","volume":"14","author":[{"given":"Yao","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(08)73394-9","article-title":"Abnormalities in insulin secretion in type 2 diabetes mellitus","author":"Guillausseau","year":"2008","journal-title":"Diabetes Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(72)90070-8","article-title":"Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis","volume":"52","author":"Dymock","year":"1972","journal-title":"Am J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(67)90276-8","article-title":"Thalassemia intermedia, with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria","volume":"42","author":"Bannerman","year":"1967","journal-title":"Am J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.02.007","article-title":"Iron and diabetes risk","volume":"17","author":"Simcox","year":"2013","journal-title":"Cell Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.05.012","article-title":"Serum adiponectin\/Ferritin ratio in relation to the risk of type 2 diabetes and insulin sensitivity","volume":"141","author":"Aregbesola","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.1038\/s41598-018-27391-4","article-title":"Prenatal iron exposure and childhood type 1 diabetes","volume":"8","author":"Stordal","year":"2018","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1038\/s41598-018-21276-2","article-title":"Iron overload accelerates the progression of diabetic retinopathy in association with increased retinal renin expression","volume":"8","author":"Chaudhary","year":"2018","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab454","article-title":"Genetic support of a causal relationship between iron status and type 2 diabetes: A mendelian randomization study","volume":"106","author":"Wang","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2015.08.017","article-title":"Current and future treatment strategies for iron overload cardiomyopathy","volume":"765","author":"Wongjaikam","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12032","article-title":"Iron homeostasis in the metabolic syndrome","volume":"43","author":"Datz","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0445-7","article-title":"Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis","volume":"49","author":"Abraham","year":"2006","journal-title":"Diabetologia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00022.2010","article-title":"Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob\/ob lep-\/-) mouse","volume":"298","author":"Cooksey","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2016.06.018","article-title":"Association of serum ferritin levels with metabolic syndrome and insulin resistance in a Chinese population","volume":"31","author":"Chen","year":"2017","journal-title":"J Diabetes Complications"},{"key":"B15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1055\/s-0042-118175","article-title":"Serum ferritin, insulin resistance, and beta-cell dysfunction: A prospective study in normoglycemic Japanese men","volume":"125","author":"Nakamura","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3469-4","article-title":"Fasting serum levels of ferritin are associated with impaired pancreatic beta cell function and decreased insulin sensitivity: a population-based study","volume":"58","author":"Bonfils","year":"2015","journal-title":"Diabetologia"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0257","article-title":"Association of multiple biomarkers of iron metabolism and type 2 diabetes: The EPIC-InterAct study","volume":"39","author":"Podmore","year":"2016","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13216","article-title":"Iron metabolism and type 2 diabetes mellitus: A meta-analysis and systematic review","volume":"11","author":"Liu","year":"2020","journal-title":"J Diabetes Investig"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.3390\/nu12113249","article-title":"Association between iron status and incident type 2 diabetes: A population-based cohort study","volume":"12","author":"Diaz-Lopez","year":"2020","journal-title":"Nutrients"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2625","article-title":"The role of iron in diabetes and its complications","volume":"30","author":"Swaminathan","year":"2007","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.107977","article-title":"Evidence of dysregulated iron homeostasis in newly diagnosed diabetics, but not in pre-diabetics","volume":"35","author":"Venkatesan","year":"2021","journal-title":"J Diabetes Complications"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.7.1087","article-title":"The homeostasis model in the San Antonio heart study","volume":"20","author":"Haffner","year":"1997","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109994","article-title":"Beta-cell function and insulin sensitivity contributions on incident diabetes in patients with endogenous cushing's syndrome","volume":"190","author":"Gong","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-1592","article-title":"Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the hemochromatosis and iron overload screening (HEIRS) study","volume":"29","author":"Acton","year":"2006","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbagen.2011.10.013","article-title":"Regulation of iron transport and the role of transferrin","volume":"1820","author":"Gkouvatsos","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation","volume":"1","author":"Wish","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.acc.2016.03.002","article-title":"Transferrin saturation: A body iron biomarker","volume":"75","author":"Elsayed","year":"2016","journal-title":"Adv Clin Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.46259","article-title":"Serum transferrin predicts end-stage renal disease in type 2 diabetes mellitus patients","volume":"17","author":"Zhao","year":"2020","journal-title":"Int J Med Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-014-0646-3","article-title":"Iron metabolism is prospectively associated with insulin resistance and glucose intolerance over a 7-year follow-up period: The CODAM study","volume":"52","author":"Wlazlo","year":"2015","journal-title":"Acta Diabetol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0631","article-title":"Biomarkers of iron metabolism are independently associated with impaired glucose metabolism and type 2 diabetes: the KORA F4 study","volume":"173","author":"Huth","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2020.721","article-title":"Serum transferrin predicts new-onset type 2 diabetes in koreans: A 4-year retrospective longitudinal study","volume":"35","author":"Kim","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004967","article-title":"Iron overload in human disease","volume":"366","author":"Fleming","year":"2012","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2011.07.014","article-title":"Non-transferrin bound iron: a key role in iron overload and iron toxicity","volume":"1820","author":"Brissot","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B35","article-title":"Is an elevated serum transferrin saturation associated with the development of diabetes","volume":"51","author":"Mainous","year":"2002","journal-title":"J Fam Pract"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0416","article-title":"Elevated transferrin saturation and risk of diabetes: three population-based studies","volume":"34","author":"Ellervik","year":"2011","journal-title":"Diabetes Care"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/apha.12256","article-title":"Iron: the hard player in diabetes pathophysiology","volume":"210","author":"Hansen","year":"2014","journal-title":"Acta Physiol (Oxf)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1042\/BST0360343","article-title":"Oxidative stress: The vulnerable beta-cell","volume":"36","author":"Lenzen","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0392","article-title":"Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis","volume":"145","author":"Cooksey","year":"2004","journal-title":"Endocrinology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-3082","article-title":"Mechanisms linking glucose homeostasis and iron metabolism toward the onset and progression of type 2 diabetes","volume":"38","author":"Fernandez-Real","year":"2015","journal-title":"Diabetes Care"},{"key":"B41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cbpa.2017.09.009","article-title":"Link of impaired metal ion homeostasis to mitochondrial dysfunction in neurons","volume":"43","author":"Nam","year":"2018","journal-title":"Curr Opin Chem Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2018.06.006","article-title":"Metabolic activation-driven mitochondrial hyperpolarization predicts insulin secretion in human pancreatic beta-cells","volume":"1859","author":"Gerencser","year":"2018","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9999612","article-title":"Mechanism of ferroptosis and its role in type 2 diabetes mellitus","volume":"2021","author":"Sha","year":"2021","journal-title":"J Diabetes Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.26097","article-title":"Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: How are they interlinked","volume":"118","author":"Rehman","year":"2017","journal-title":"J Cell Biochem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1039\/c6mt00214e","article-title":"Fe-oxy adducts of heme-abeta and heme-hIAPP complexes: intermediates in ROS generation","volume":"8","author":"Seal","year":"2016","journal-title":"Metallomics"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1021\/ic4001413","article-title":"Heme bound amylin: spectroscopic characterization, reactivity, and relevance to type 2 diabetes","volume":"52","author":"Mukherjee","year":"2013","journal-title":"Inorg Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3873420","article-title":"Ferroptosis as a novel determinant of beta-cell death in diabetic conditions","volume":"2022","author":"Stancic","year":"2022","journal-title":"Oxid Med Cell Longev"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1143919\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:03:50Z","timestamp":1680519830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1143919\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":47,"alternative-id":["10.3389\/fendo.2023.1143919"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1143919","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"article-number":"1143919"}}